Patents by Inventor Terry W. Moody

Terry W. Moody has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination therapy with VIP antagonist
    Patent number: 6630124
    Abstract: The present invention relates to combination therapy using a pharmaceutical composition comprising a polypeptide which is an antagonist of the vasoactive intestinal polypeptide (VIP) and a chemotherapeutic agent. Methods of using the pharmaceutical composition are also disclosed.
    Type: Grant
    Filed: January 9, 2002
    Date of Patent: October 7, 2003
    Assignees: Ramot-University Authority for Applied Research and Industrial Development Ltd., Yeda Research and Development Co. Ltd., The United States of America as represented by the Department of Health and Human Services
    Inventors: Illana Gozes, Mati Fridkin, Edgar Gelber, Terry W. Moody, Douglas C. Brenneman
  • Compositions and methods for treating small cell and nonsmall cell lung cancers
    Patent number: 5721211
    Abstract: Compositions and methods of use thereof for treating small cell and nonsmall cell lung cancers in mammals are disclosed. The compositions comprise substances that inhibit the lung cancer cell growth and proliferation actions of the biological response modifier vasoactive intestinal polypeptide, such as specific thymosins or analogues, derivatives and fragments thereof, anti-vasoactive intestinal polypeptide receptor polyclonal or monoclonal antibodies, and antibodies directed against the vasoactive intestinal polypeptide molecule itself.
    Type: Grant
    Filed: December 22, 1993
    Date of Patent: February 24, 1998
    Assignee: The George Washington University
    Inventor: Terry W. Moody
  • Superactive VIP antagonists
    Patent number: 5565424
    Abstract: The present invention relates to a family of peptides encoding antagonists of the vasoactive intestinal peptide (VIP) designed to distinguish multiple receptors that mediate VIP neurotransmission, neurotrophism and cell division. The invention also relates to methods of using these peptides to antagonize VIP-associated activity and function. The invention further relates to pharmaceutical compositions dsigned to inhibit VIP-associated activity.
    Type: Grant
    Filed: February 7, 1994
    Date of Patent: October 15, 1996
    Assignee: Ramot - University Authority for Applied Research and Industrial Development Ltd.
    Inventors: Illana Gozes, Douglas E. Brenneman, Matityahu Fridkin, Terry W. Moody
  • Compositions and methods for treating small cell and nonsmall cell lung cancers
    Patent number: 5273963
    Abstract: Compositions and methods of use thereof for treating small cell and nonsmall cell lung cancers in mammals are disclosed. The compositions comprise substances that inhibit the lung cancer cell growth and proliferation actions of the biological response modifier vasoactive intestinal polypeptide, such as specific thymosins or analogues, derivatives and fragments thereof, anti-vasoactive intestinal polypeptide receptor polyclonal or monoclonal antibodies, and antibodies directed against the vasoactive intestinal polypeptide molecule itself.
    Type: Grant
    Filed: March 29, 1991
    Date of Patent: December 28, 1993
    Assignee: The George Washington University
    Inventor: Terry W. Moody